Jump to top menu Jump to main menu Jump to content
erlenmyer-research
Research group/lab

Bierings lab

Storage and secretion of von Willebrand factor

About our research group/lab

Our research

In our lab we study the molecular mechanisms of von Willebrand factor secretion in endothelial cells in order to understand how defects in these mechanism can lead to bleeding disorders.



Using innovative (patient-derived) cellular model systems such as endothelial colony forming cells (ECFCs; formerly known as blood outgrowth endothelial cells, BOECs) we are systematically investigating the mechanisms that control how secretory organelles such as Weibel-Palade bodies (WPBs) are formed and how they acquire the molecular machinery to undergo exocytosis.
Over the years we have made substantial contributions to the elucidation of the signaling networks and the role of membrane proteins, such as Rab GTPases, Rab effectors and SNARE proteins, in the formation and exocytosis of WPBs.

Together with our clinical partners within the Erasmus MC (Prof. dr. Frank Leebeek, Hematology and Prof. dr. Marjon Cnossen, Pediatric Hematology) and beyond we use patient-derived ECFCs to study the pathogenic mechanisms of bleeding disorders such as von Willebrand disease (VWD). We also use this model system as a pre-clinical platform to evaluate gene correction and gene therapy strategies for von Willebrand disease (VWD), with the ultimate aim to develop personalized therapies for VWD patients.


Collaborations

Internal collaboration

External collaborations:

NWO-TTW program on personalized medicine for von Willebrand disease:

NWO-NWA SYMPHONY consortium "Orchestrating personalised treatment for patients with bleeding disorders"

NWO-ENW-M2

Funding & Grants


Our team

  • Ruben Bierings, principal investigator
  • Petra Burgisser, research technician
  • Iris van Moort, postdoc
  • Marije Kat, PhD student (Sanquin)
  • Sebastiaan Laan, PhD student (LUMC)